Suchergebnisse - "Reinmuth, Niels"

PubPharm (199)

1

Development and Update of Guideline-based Quality Indicators in Lung Cancer

enthalten in: Pneumologie (Stuttgart, Germany) | 2024

von Utzig, M. | Hoffmann, H. | Reinmuth, N. | +5

2

Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer

enthalten in: JCO precision oncology | 2024

von Christopoulos, P. | Harel, M. | McGregor, K. | +34

3

Sotorasib in KRAS G12C-mutated non-small cell lung cancer : A multicenter real-world experience from the compassionate use program in Germany

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Stratmann, J. | Althoff, F. | Doebel, P. | +27

4

A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer : Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study

enthalten in: Clinical lung cancer | 2024

von Garon, E. | Cho, B. | Luft, A. | +17

5

Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN) : Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Paz-Ares, L. | Garassino, M. | Chen, Y. | +19

CommentIn: Clin Cancer Res. 2024 Feb 16;30(4):652-654. - PMID 38085269

6

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial

enthalten in: Journal for immunotherapy of cancer | 2024

von Carbone, D. | Ciuleanu, T. | Schenker, M. | +23

7

Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy

enthalten in: Frontiers in immunology | 2024

von Bar, J. | Leibowitz, R. | Reinmuth, N. | +24

8

Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy

enthalten in: bioRxiv.org | 2024

von Bar, J. | Leibowitz, R. | Reinmuth, N. | +24

9

Trastuzumab deruxtecan (Enhertu) : Antikörper-Wirkstoff-Konjugat zur Behandlung des fortgeschrittenen, HER2-mutiertem, nicht-kleinzelligen Lungenkarzinoms (NSCLC)

Erschienen: Stuttgart, Thieme, März 2024

Drug report

von Reinmuth, N.

10

Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Garon, E. | Cho, B. | Luft, A. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]